BackAMAG Pharmaceuticals Overview

AMAG Pharmaceuticals Total Liabilities

AMAG Pharmaceuticals's total liabilities is $480M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$478.33M
1.57% YoYΔ $-7.65M vs prior year quarter

Peer average

Loading

AMAG Pharmaceuticals Total Liabilities History

Loading

AMAG Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

AMAG Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AMAG Pharmaceuticals (AMAG) FAQ

As of the most recent data (September 2020), AMAG shows a total liabilities of $480M. That compares with $490M in the prior-year period — down 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMAG's total liabilities is now $480M (was $490M) — a 1.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AMAG Pharmaceuticals is outperforming or lagging.

Tracking AMAG's total liabilities over time shows whether AMAG Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $490M in the prior-year period — down 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has AMAG Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $480M) with ownership activity and broader fundamentals.

AMAG Pharmaceuticals's total liabilities is $480M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.